Search Page

1

Cite

Share

Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.

Hurtado-de-Mendoza A, Cabling ML, Lobo T, Dash C, Sheppard VB. Hurtado-de-Mendoza A, et al. Among authors: lobo t. Clin Breast Cancer. 2016 Aug;16(4):247-255.e3. doi: 10.1016/j.clbc.2016.03.006. Epub 2016 Mar 31. Clin Breast Cancer. 2016. PMID: 27133733 Free PMC article. Review.

Cite

Share

2

Cite

Share

Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control.

Taylor KL, Fallon S, Subramaniam D, Davis K, To C, Lobo T, Tercyak KP, Friberg J, Tynan M, Russell E, Ahmed W, Ponder MC, Cusaac L, Thompson J, Gardner K, Kim C, Weiner LM. Taylor KL, et al. Among authors: lobo t. J Cancer Surviv. 2020 Feb;14(1):53-58. doi: 10.1007/s11764-019-00826-1. Epub 2019 Nov 4. J Cancer Surviv. 2020. PMID: 31686365

Cite

Share

3

Cite

Share

Decision-making processes among men with low-risk prostate cancer: A survey study.

Hoffman RM, Van Den Eeden SK, Davis KM, Lobo T, Luta G, Shan J, Aaronson D, Penson DF, Leimpeter AD, Taylor KL. Hoffman RM, et al. Among authors: lobo t. Psychooncology. 2018 Jan;27(1):325-332. doi: 10.1002/pon.4469. Epub 2017 Jul 13. Psychooncology. 2018. PMID: 28612468 Free PMC article.

Cite

Share

4

Cite

Share

Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.

Hoffman RM, Lobo T, Van Den Eeden SK, Davis KM, Luta G, Leimpeter AD, Aaronson D, Penson DF, Taylor K. Hoffman RM, et al. Among authors: lobo t. Med Decis Making. 2019 Nov;39(8):962-974. doi: 10.1177/0272989X19883242. Epub 2019 Oct 21. Med Decis Making. 2019. PMID: 31631745 Free PMC article.

Cite

Share

5

Cite

Share

Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine.

Sheppard VB, Hurtado-de-Mendoza A, Zheng YL, Wang Y, Graves KD, Lobo T, Xu H, Jennings Y, Tolsma D, Trout M, Robinson BE, McKinnon B, Tadesse M. Sheppard VB, et al. Among authors: lobo t. J Cancer Surviv. 2018 Feb;12(1):74-81. doi: 10.1007/s11764-017-0646-8. Epub 2017 Nov 16. J Cancer Surviv. 2018. PMID: 29147853

Cite

Share

6

Cite

Share

The characteristics of patients who quit smoking in the year following a cancer diagnosis.

Gummerson SP, Lowe JT, Taylor KL, Lobo T, Jensen RE. Gummerson SP, et al. Among authors: lobo t. J Cancer Surviv. 2022 Feb;16(1):111-118. doi: 10.1007/s11764-021-01009-7. Epub 2021 Feb 27. J Cancer Surviv. 2022. PMID: 33641030

Cite

Share

7

Cite

Share

Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.

Taylor KL, Deros DE, Fallon S, Stephens J, Kim E, Lobo T, Davis KM, Luta G, Jayasekera J, Meza R, Stanton CA, Niaura RS, Abrams DB, McKee B, Howell J, Ramsaier M, Batlle J, Dornelas E, Parikh V, Anderson E. Taylor KL, et al. Among authors: lobo t. Contemp Clin Trials. 2019 Jul;82:25-35. doi: 10.1016/j.cct.2019.05.006. Epub 2019 May 23. Contemp Clin Trials. 2019. PMID: 31129371 Free PMC article.

Cite

Share

8

Cite

Share

Complementary and Alternative Medicine Use and Latina Breast Cancer Survivors' Symptoms and Functioning.

Rush CL, Lobo T, Serrano A, Blasini M, Campos C, Graves KD. Rush CL, et al. Among authors: lobo t. Healthcare (Basel). 2016 Oct 31;4(4):80. doi: 10.3390/healthcare4040080. Healthcare (Basel). 2016. PMID: 27809225 Free PMC article.

Cite

Share

9

Cite

Share

Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Taylor KL, Luta G, Hoffman RM, Davis KM, Lobo T, Zhou Y, Leimpeter A, Shan J, Jensen RE, Aaronson DS, Van Den Eeden SK. Taylor KL, et al. Among authors: lobo t. Transl Behav Med. 2018 Mar 1;8(2):156-165. doi: 10.1093/tbm/ibx005. Transl Behav Med. 2018. PMID: 29425377 Free PMC article.

Cite

Share

10

Cite

Share

Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Taylor KL, Hoffman RM, Davis KM, Luta G, Leimpeter A, Lobo T, Kelly SP, Shan J, Aaronson D, Tomko CA, Starosta AJ, Hagerman CJ, Van Den Eeden SK. Taylor KL, et al. Among authors: lobo t. Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27257092 Free PMC article.

Cite

Share